why choose us

First received: August 23, 2022

Clinical Trial: Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Migraine

Study Type: INTERVENTIONAL


Official Title: A Phase 4, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With a History of Inadequate Response to

Brief Summary: This study is being conducted to evaluate the efficacy and tolerability of rimegepant for migraine prophylaxis in adults with a history of inadequate response to oral preventive medications

Read more